Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Maria Celeste Varela"'
Autor:
Maria Celeste Varela, Roberto R. Rosato, Matthew Ojeda Saavedra, Agustina Taglialegna, James J. Davis, Melanie Roch, Scott Wesley Long, Adriana E. Rosato, Rafael E Hernandez, Lucas R. Hoffman, Warren E. Rose
Publikováno v:
Communications Biology, Vol 3, Iss 1, Pp 1-10 (2020)
Communications Biology
Communications Biology
Chronic airways infection with methicillin-resistant Staphylococcus aureus (MRSA) is associated with worse respiratory disease cystic fibrosis (CF) patients. Ceftaroline is a cephalosporin that inhibits the penicillin-binding protein (PBP2a) uniquely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14e9de3c8d4d919502e620977054eded
http://link.springer.com/article/10.1038/s42003-020-01313-5
http://link.springer.com/article/10.1038/s42003-020-01313-5
Publikováno v:
J Antimicrob Chemother
Background Tedizolid is a protein synthesis inhibitor in clinical use for the treatment of Gram-positive infections. Pulmonary MRSA infections are a growing problem in patients with cystic fibrosis (CF) and the efficacy of tedizolid-based therapy in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27f3f7a771baa0224aa1159f45337c94
https://europepmc.org/articles/PMC7850011/
https://europepmc.org/articles/PMC7850011/
Publikováno v:
mSphere, Vol 4, Iss 1 (2019)
mSphere, Vol 4, Iss 1, p e00557-18 (2019)
mSphere, Vol 4, Iss 1, p e00557-18 (2019)
Methicillin-resistant Staphylococcus aureus (MRSA) threatens human health in hospital and community settings. The lipopeptide antibiotic daptomycin (DAP) is a frequently used treatment option for MRSA infection. DAP exposure can cause bacterial resis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c802aab424ccb8953f9a983c94720222
https://journals.asm.org/doi/10.1128/mSphere.00557-18
https://journals.asm.org/doi/10.1128/mSphere.00557-18
Methicillin-resistant Staphylococcus aureus (MRSA) acquisition in cystic fibrosis (CF) patients confers a worse clinical outcome with increased rate of declined lung function. Telavancin, an approved lipoglycopeptide used to treat infections due to S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae0a6a76bcf4ee28ca76883bf58bd542
https://doi.org/10.1101/319210
https://doi.org/10.1101/319210
Publikováno v:
Antimicrobial agents and chemotherapy. 62(9)
Methicillin-resistant Staphylococcus aureus (MRSA) acquisition in cystic fibrosis (CF) patients confers a clinical outcome worse than that in non-CF patients with an increased rate of declined lung function. Telavancin, an approved lipoglycopeptide u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d36ff1f0b347de6fd7719e0efc526b7a
https://pubmed.ncbi.nlm.nih.gov/29914961
https://pubmed.ncbi.nlm.nih.gov/29914961
Publikováno v:
Journal of Antimicrobial Chemotherapy (JAC); Jan2020, Vol. 75 Issue 1, p126-134, 9p
Autor:
Varela, Maria Celeste1, Roch, Melanie1, Taglialegna, Agustina1, Long, Scott W.1, Saavedra, Matthew Ojeda1, Rose, Warren E.2, Davis, James J.3,4, Hoffman, Lucas R.5,6, Hernandez, Rafael E.5,6, Rosato, Roberto R.7, Rosato, Adriana E.1,8 a.rosato@ruhealth.org
Publikováno v:
Communications Biology. 10/22/2020, Vol. 3 Issue 1, pN.PAG-N.PAG. 1p.